Novarum granted European patent for smartphone diagnostic technology

Smartphone diagnostic specialist Novarum™ DX has achieved a significant milestone in the development of its revolutionary technology after being officially granted a European patent.

Novarum has been awarded the patent (EP 12718728.4) for its smartphone diagnostic technology by the European Patent Office (EPO), having already secured the equivalent patent for its technology in the United States earlier this year.

The patents protect Novarum’s image-capture technology which transforms a smartphone into a diagnostic reader when using the mobile’s camera to accurately scan the results of a rapid test.

Since the acquisition by BBI Solutions in 2016, Novarum has expanded its patent portfolio which now includes: China, Japan, Russia, the United States and Europe with a number of other territories pending.

Novarum Founder and BBI Group Head of Mobile, Dr Neil Polwart said: “The European patent bolsters Novarum’s position as a leader in smartphone-enabled point of care diagnostics”.

“As the second patent to have been awarded this year, we’re now able to protect our intellectual property across two key territories, the US and Europe.”

“Our technology corrects misalignments when reading diagnostic tests using the camera feature on a smartphone without additional hardware, ensuring that our solution is robust in delivering test results of lab quality.”

“Our patents safeguard our intellectual property and reaffirm Novarum’s position as pioneers for next generation diagnostic technologies.”

For more information about how Novarum is revolutionising point of care diagnostics, visit: www.novarumdx.com

Economy Secretary opens BBI’s new global headquarters in Crumlin

Economy Secretary, Ken Skates has been in Crumlin to open the new £14m global headquarters of life sciences company, BBI Group.

Following a £1.8m package of Welsh Government support, the company has chosen the Caerphilly town as the location for its new global headquarters.

It has also centralised its manufacturing and development activities from sites in Blaenavon, Cardiff and Dundee onto one new state of the art facility site in Crumlin.

The move to Crumlin will see over 360 jobs being safeguarded and created in Wales by 2020.

This means that in line with the ambitions of the Welsh Government’s high level plan, Our Valleys, Our Future, BBI’s move will deliver high quality career opportunities in the South Wales Valleys and provide a significant boost to the local economy.

Economy Secretary, Ken Skates said: “As a highly successful company with a turnover of more than £60m and a strategically important player in the global life science sector, BBI Group is already a made-in-Wales success story.

“I am delighted that Welsh Government support has enabled the company to establish its global headquarters here and centralise its manufacturing and development activities in Crumlin, bringing new and high-quality job opportunities to the South Wales Valleys.

“This is absolutely in line with the ambitions of our high-level plan Our Valleys Our Future, and with the aspirations of my Economic Action Plan, which aims to ensure that the fruits of economic prosperity fall much more evenly across Wales.

“The Economic Action Plan is also clear about the economic growth opportunities of attracting global headquarters to Wales and our ambition to build on our success in this area.

“I am delighted to see BBI Group’s new state of the art facility in Crumlin first hand and wish the company every success in its new home.”

BBI Group Chairman Alan Peterson said: “The opening of our new Global Headquarters is a significant step towards realising our strategic long-term growth plans. It gives us the opportunity to compete more effectively in our key markets in Europe, USA and China.

“The Crumlin site enables BBI to drive our customers’ future growth by expanding our capacity to provide key reagents and services for the healthcare diagnostics industry. We’re delighted that our Global Headquarters is now open and we are able to contribute to the local economy and offer quality job opportunities to the local community.”

BBI Group appoints new CEO

The BBI Group has appointed a new CEO as it moves to its global headquarters in Crumlin, South Wales.

Mario Gualano, previously BBI’s Global Head of Commercial, took up the role of CEO following the departure of former CEO Lyn Rees.

Having completed his PhD in Microbiology and Immunodiagnostics at Cardiff University and his MBA at Henley, Mario brings over twenty years’ experience within the microbiology / diagnostics sector within Thermo-Fisher Scientific, most recently as President of the microbiology division.

Chairman Alan Peterson said: “I’m delighted that Mario Gualano will be taking up the helm as BBI moves to a world-class facility. Mario has a wealth of commercial, technical and operational experience which will be invaluable as BBI continues its growth journey.

“The Board would like to thank Lyn for his hard work, energy and enthusiasm over the past 17 years and wish him all the best in his future endeavours.”

Maine Biotechnology Services

BBI Group acquires Maine Biotechnology Services

The BBI Group, partner to the world’s leading diagnostic and healthcare organisations, has entered into a definitive agreement to acquire the Maine Biotechnology Services, Inc. (MBS) located in Portland, Maine (USA).

The acquisition of MBS will expand BBI’s portfolio during a period of expansion and growth. The company provides a range of products to the diagnostic, healthcare, research food sectors globally. MBS will add antibody development to its capability and product range.

The acquisition of MBS perfectly complements the company’s current product portfolio and coincides with its commercial team expansion, giving the company important new technology and products.

Dr Joseph Chandler, Founder and President of MBS, said: “The BBI Group was aware of our reputation in the market for high quality antibody products services. They currently have no capacity for antibody development and manufacture and, with a waiting customer base for this, MBS is a logical addition to their business. They are on an ambitious growth plan and I know that MBS will be a key part of their future plans.”

Cyber Essentials Plus

BBI awarded Cyber Essentials Plus certification

BBI Group is delighted to have been awarded Cyber Essentials Plus certification, the UK Government scheme that helps protect businesses from cyber-attacks.A copy of our certificate can be found here

BBI Group – Cyber Essentials Plus Certificate

The scheme has been designed to help protect UK businesses by preventing the most common forms of cyber-attacks and to make the UK a safer place to do business online.The Cyber Essentials Plus scheme provides a higher level of assurance, tested by a qualified and independent assessor who simulates hacking and phishing attacks.

BBI Group CEO Lyn Rees, said: “This achievement is a culmination of efforts over the last six months, involving many improvements to our IT processes and software security.

“The accreditation not only demonstrates the robustness of BBI’s IT infrastructure, but as Cyber Essentials is a mandatory requirement for government contracts this ensures our BBI Detection division can continue working with our MOD partners.”

To learn more about the Cyber Essentials scheme, visit their page on the UK Government website.

BBI Group Global Headquarters

BBI Group announce £14m investment to boost capacity and long-term growth

BBI Group today (February 7th, 2017) announced a new £14m investment plan for 2017 which will include a new global HQ and manufacturing centre of excellence for the company in South Wales.

The announcement takes the company’s overall investment to approximately £20m across 2016 and 2017.

The plans – supported by a £1.8m grant from the Welsh Government – will see BBI Group move to a new 120,000 sq ft headquarters at Crumlin, Caerphilly with excellent links to the M4 corridor and Cardiff International Airport.

The investment will aim, following consultation and internal business review, to consolidate BBI Group’s existing operations in Blaenavon, Cardiff and Dundee, providing improved manufacturing and enzyme production facilities to serve the global diagnostics and healthcare marketplace.

It will also give the company the pedigree to compete more effectively in the expanding markets in Europe, USA and China.

With Welsh Government and local authority backing, the investment also aims to create around 50 new positions up to 2020. This will provide excellent career opportunities in the South Wales Valleys region, foster closer links to the scientific and academic community, and provide a significant boost for the local economy.

Economy Cabinet Secretary Ken Skates welcomed the news today and said:

“BBI Group is a made-in-Wales success story; a highly successful company and a strategically important player in the life science sector globally.

“I am particularly pleased WG support helped secure this significant investment for Wales. Founded in 1986 as a Cardiff University spin out, BBI Group has grown to become a £60m turnover company and this expansion project will secure the company’s long term sustainable future in Wales.

“It will not only create and safeguard a significant number of high quality jobs but will also support the local economy through an annual spend of more than £1m with supply chain companies. In addition, the fit out and alterations of the building will support around 75 FTE jobs in the construction industry.”